Skip to main content

Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

botanically-derived agent RH324

An orally bioavailable, botanically-derived substance, with potential antineoplastic activity. Though the nature of the plant has yet to be fully elucidated, the botanically-derived agent RH324 contains all the plant's natural constituents, including proteins, amino acids, various fatty acids, carbohydrates, vitamins, minerals, and phytochemicals. Upon oral administration, the botanically-derived agent RH324 may exert its activity by a variety of as of yet not elucidated mechanisms of action.

Check for active clinical trials using this agent View this agent in the NCI Thesaurus

Code name:	RH 324 RH-324 RH324

botanically-derived agent RH324

Search NCI's Drug Dictionary